Aim BRAF mutation inhibits many tumour suppressor genes, increases pro-angiogenic molecules and reduces radioactive iodine uptake of tumour in papillary thyroid cancer (PTC), giving it more aggressive clinical characteristics. In this study, we aimed to evaluate the effect of BRAF V600E mutation on the clinicopathological features in patients with ...

By Mehmet Celik, Buket Yılmaz Bulbul, Semra Ayturk, Yusuf Durmus, Hakan Gurkan, Nuray Can, Ebru Tastekin, Funda Ustun, Atakan Sezer, Sibel Guldiken